Telo Genomics Announces Study Results Showing That TeloView® Differentiates Between Stable Smoldering Multiple Myeloma Patients and Patients That Progressed to Active Multiple Myeloma

Joey Cohen
Medication Adherence

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice